Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 1.02 Million shares of FOLD, which is worth approximately $9.68 Million. The most recent transaction as insider was on Mar 18, 2022, when has been sold 10,940 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $109,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.02M

10.21% 3M change

5.77% 12M change

Total Value Held $9.68 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2022	SELL Open market or private sale	$109,400 $10.0 p/Share	10,940 Reduced 1.84%	585,015 Common Stock
Mar 18 2022	BUY Exercise of conversion of derivative security	$38,618 $3.53 p/Share	10,940 Added 1.8%	595,955 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	104,603 Added 13.17%	689,618 Common Stock
Jan 14 2022	SELL Payment of exercise price or tax liability	$341,025 $10.53 p/Share	32,386 Reduced 5.25%	585,015 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	63,317 Added 9.3%	617,401 Common Stock
Jan 04 2022	SELL Payment of exercise price or tax liability	$91,953 $12.48 p/Share	7,368 Reduced 1.31%	554,084 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$60,356 $12.11 p/Share	4,984 Reduced 1.21%	406,741 Common Stock

Jan 03 2022	SELL Open market or private sale	$64,874 $11.86 p/Share	5,470 Reduced 1.33%	406,741 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$19,309 $3.53 p/Share	5,470 Added 1.31%	412,211 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	154,711 Added 21.6%	561,452 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$322,776 $11.55 p/Share	27,946 Reduced 6.36%	411,725 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$203,245 $11.55 p/Share	17,597 Reduced 3.85%	439,671 Common Stock
Dec 22 2021	SELL Open market or private sale	$35,100 $11.7 p/Share	3,000 Reduced 0.65%	457,268 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$13,140 $4.38 p/Share	3,000 Added 0.65%	460,268 Common Stock
Dec 01 2021	SELL Open market or private sale	$115,665 $11.0 p/Share	10,515 Reduced 2.25%	457,268 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$46,056 $4.38 p/Share	10,515 Added 2.2%	467,783 Common Stock
Nov 01 2021	SELL Open market or private sale	$119,030 $11.32 p/Share	10,515 Reduced 2.25%	457,268 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$46,056 $4.38 p/Share	10,515 Added 2.2%	467,783 Common Stock
Oct 01 2021	SELL Open market or private sale	$105,150 $10.0 p/Share	10,515 Reduced 2.25%	457,268 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$46,056 $4.38 p/Share	10,515 Added 2.2%	467,783 Common Stock
Sep 01 2021	SELL Open market or private sale	$120,922 $11.5 p/Share	10,515 Reduced 2.25%	457,268 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$46,056 $4.38 p/Share	10,515 Added 2.2%	467,783 Common Stock
Aug 05 2021	SELL Open market or private sale	$210,701 $10.02 p/Share	21,028 Reduced 4.4%	457,268 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$92,103 $4.38 p/Share	21,028 Added 4.21%	478,296 Common Stock
Jun 07 2021	SELL Payment of exercise price or tax liability	$174,888 $10.08 p/Share	17,350 Reduced 3.66%	457,268 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account